Chemours Co CC.N reported quarterly adjusted earnings of 58 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 38 cents. The mean expectation of ten analysts for the quarter was for earnings of 46 cents per share. Wall Street expected results to range from 38 cents to 53 cents per share.
Revenue rose 5% to $1.62 billion from a year ago; analysts expected $1.57 billion.
Chemours Co's reported EPS for the quarter was a loss of $2.54.
The company reported a quarterly loss of $381 million.
Chemours Co shares had risen by 6.6% this quarter and lost 27.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 18.5% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Chemours Co is $15.00, about 15.8% above its last closing price of $12.63
This summary was machine generated from LSEG data August 5 at 10:44 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)